Life Expectancy News and Research RSS Feed - Life Expectancy News and Research

Life expectancy is the expected (in the statistical sense) number of years of life remaining at a given age. It is denoted by e''x'', which means the average number of subsequent years of life for someone now aged ''x'', according to a particular mortality experience.
Finding opens avenues of research toward precision treatments to boost life expectancy for CF patients

Finding opens avenues of research toward precision treatments to boost life expectancy for CF patients

Mutation of one gene is all it takes to get cystic fibrosis (CF), but disease severity depends on many other genes and proteins. For the first time, researchers at the UNC School of Medicine have identified genetic pathways - or clusters of genes - that play major roles in why one person with CF might never experience the worse kinds of symptoms while another person will battle severe airway infection for a lifetime. [More]
Research findings lay groundwork for improving treatment assessment for men with prostate cancer

Research findings lay groundwork for improving treatment assessment for men with prostate cancer

UCLA researchers have found that radiation therapy is the most common treatment for men with prostate cancer regardless of the aggressiveness of the tumor, risk to the patient and overall patient prognosis. These findings lay the groundwork for improved treatment assessment by physicians and to better inform men fighting the disease. [More]
Videos on resuscitation, assistive procedures may help patients make better end-of-life decisions

Videos on resuscitation, assistive procedures may help patients make better end-of-life decisions

Most seriously ill elderly people who view video material about the pros and cons of available resuscitation and assistive procedures decide they would rather not receive such treatment when the time comes. So says Areej El-Jawahri of Massachusetts General Hospital and the Harvard Medical School in the US, lead author of a study in the Journal of General Internal Medicine, published by Springer. [More]
Eliglustat drug improves liver, spleen size and hemoglobin level in adults with Gaucher disease type 1

Eliglustat drug improves liver, spleen size and hemoglobin level in adults with Gaucher disease type 1

Among previously untreated adults with Gaucher disease type 1, a genetic disease in which there is improper metabolism due to a defect in an enzyme, treatment with the drug eliglustat resulted in significant improvements in liver and spleen size hemoglobin level, and platelet count, according to a study in the February 17 issue of JAMA. [More]
Study lays groundwork for building consensus on successful aging

Study lays groundwork for building consensus on successful aging

Scholars have long debated what successful aging is, how to measure it, and how to promote it. But the latest issue of The Gerontologist lays the groundwork for building consensus on the topic -- while pointing out that the answer may differ among academics and the general public, as well as across populations and demographic groups. [More]
Despite growing shortage of donor hearts, surgeons, transplant centers reject marginal hearts

Despite growing shortage of donor hearts, surgeons, transplant centers reject marginal hearts

Surgeons and transplant centers nationwide increasingly have rejected hearts donated for transplantation despite a growing need for them, according to a new study by researchers at the Stanford University School of Medicine. [More]
Scientists identify new cellular pathway affected in cystinosis

Scientists identify new cellular pathway affected in cystinosis

Scientists at The Scripps Research Institute have identified a new cellular pathway that is affected in cystinosis, a rare genetic disorder that can result in eye and kidney damage. [More]
DNA strands predict life expectancy

DNA strands predict life expectancy

BYU biologist Jonathan Alder has a startling secret he doesn't freely share: he knows when most of us are going to die. [More]
Deaf people have high levels of risk factors for common conditions

Deaf people have high levels of risk factors for common conditions

Deaf people who sign have poorer health than the general population, according to a study led by researchers from the School for Social and Community Medicine at the University of Bristol, UK. [More]
Meditation appears to help preserve the brain's gray matter

Meditation appears to help preserve the brain's gray matter

Since 1970, life expectancy around the world has risen dramatically, with people living more than 10 years longer. That's the good news. [More]
Half of people in the UK will develop cancer, says new estimate

Half of people in the UK will develop cancer, says new estimate

One in two people will develop cancer in their lifetime, according to new calculations from Cancer Research UK. [More]
Study on life expectancy in fruit flies may pave way for human 'longevity'

Study on life expectancy in fruit flies may pave way for human 'longevity'

Some studies on the genetic roots of aging will need a second look after the discovery that a common lab chemical can extend the life span of female fruit flies by 68 percent. [More]
UC study reveals that bariatric surgery may cut life expectancy for super obese patients with diabetes

UC study reveals that bariatric surgery may cut life expectancy for super obese patients with diabetes

Bariatric surgery improves life expectancy for many obese diabetic patients, but it may cut life expectancy for patients who are super obese with very high body mass indexes, according to a University of Cincinnati researcher. [More]
New book explores the outcomes of an aging American workforce

New book explores the outcomes of an aging American workforce

As chief of the Associated Press' Tokyo bureau, Joseph Coleman wrote a story about an agricultural cooperative in southwestern Japan where organizers put aging residents to work selling leaves and flowers as seasonal garnishes for high-class restaurants. [More]
Bern researchers develop active substance for treating Duchenne muscular dystrophy

Bern researchers develop active substance for treating Duchenne muscular dystrophy

Duchenne muscular dystrophy is a congenital disease which causes muscle degeneration and eventual death in teenagers. Recently, researchers from Bern developed an active substance, which they together with an international team tested successfully. [More]
Multiplexed testing for EGFR and ALK gene rearrangements may be cost-effective for NSCLC treatment

Multiplexed testing for EGFR and ALK gene rearrangements may be cost-effective for NSCLC treatment

Multiplexed genetic screening for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) gene rearrangements and subsequent biomarker-guided treatment is cost-effective compared with standard chemotherapy treatment without any molecular testing in the metastatic non-small cell lung cancer (NSCLC) setting in the United States. [More]
DePuy Synthes Spine receives 510(k) clearance to market SYNAPSE OCT System with posterior cervical screws

DePuy Synthes Spine receives 510(k) clearance to market SYNAPSE OCT System with posterior cervical screws

DePuy Synthes Spine today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its SYNAPSETM Occipital-Cervical-Thoracic (OCT) System with posterior cervical screws, the first time cervical screws have been indicated for use with a screw-rod posterior fixation system. [More]
Study: Targeted biopsy technique better than standard biopsy at detecting high-risk prostate cancer

Study: Targeted biopsy technique better than standard biopsy at detecting high-risk prostate cancer

Among men undergoing biopsy for suspected prostate cancer, targeted magnetic resonance/ultrasound fusion biopsy, compared with a standard biopsy technique, was associated with increased detection of high-risk prostate cancer and decreased detection of low-risk prostate cancer, according to a study in the January 27 issue of JAMA. [More]
Yale researcher receives 2015 Frontiers of Knowledge Award in Biomedicine

Yale researcher receives 2015 Frontiers of Knowledge Award in Biomedicine

A Spanish foundation has awarded a major scientific prize to Yale researcher Joseph Schlessinger and two colleagues in recognition of their work leading to the first personalized treatments for cancer. The 2015 Frontiers of Knowledge Award in Biomedicine from the Madrid-based BBVA Foundation includes a €400,000 cash prize. [More]
Researchers turn clinical experience in multiple myeloma treatment into instructive review for physicians

Researchers turn clinical experience in multiple myeloma treatment into instructive review for physicians

Multiple myeloma is a malignant disease characterised by proliferation of clonal plasma cells in the bone marrow and typically accompanied by the secretion of monoclonal immunoglobulins that are detectable in the serum or urine. Increased understanding of the microenvironmental interactions between malignant plasma cells and the bone marrow niche, and their role in disease progression and acquisition of therapy resistance, has helped the development of novel therapeutic drugs for use in combination with cytostatic therapy. [More]
Advertisement
Advertisement